Breast cancer, the most common type of cancer affecting women, encompasses a collection
of histologic (mainly ductal and lobular) and molecular subtypes exhibiting diverse clinical …

Roughly 50% of cancer cases occur in people aged 65 years or older. Older people are
often diagnosed at a later stage and might receive less (intensive) treatment, which might …

Immune infiltration of tumors is closely associated with clinical outcome in renal cell
carcinoma (RCC). Tumor‐infiltrating immune cells (TIIC s) regulate cancer progression and …

Invasive lobular carcinoma (ILC) is the most common of the breast cancer special types,
accounting for up to 15% of all breast cancer cases. ILCs are noted for their lack of E …

Background Invasive lobular breast cancer (ILC) is the second most common type of breast
cancer after invasive breast cancer of no special type (NST), representing up to 15% of all …

The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly
improved survival in several cancer settings. A subgroup of women with breast cancer (BC) …

T cell-centric immunotherapies have shown modest clinical benefit thus far for estrogen
receptor-positive (ER+) breast cancer. Despite accounting for 70% of all breast cancers …

Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …

Invasive lobular carcinoma (ILC) is the second most common histologic subtype of breast
cancer after invasive ductal carcinoma (IDC), accounting for 10–15% of all breast cancer …

Studies have shown that the presence of tumor infiltrating lymphocytes (TILs) in Triple
Negative Breast Cancer (TNBC) is associated with better prognosis. However, the molecular …